Equillium, Inc. (EQ)

NASDAQ

$1.50

$--

(0.00%)

Pre-Market

Equillium, Inc. (EQ) Live Price Chart

Last updated: ⁦2026-10-13 10:25:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Equillium, Inc. (EQ) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.50, with a market capitalisation of $89.41M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.76 to $3.54. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$89.41M
Open	$1.50
Day's High	$65.50
Day's Low	$0.27
Previous Close	$1.50
Volume	748.00
Average Volume	552.66K
P/E Ratio	--
52-Week High	$3.54
52-Week Low	$0.76
Dividend Yield	--
Earnings Date	--

Equillium, Inc. (EQ) Pre-Market Stock Price

Equillium, Inc. (EQ) is trading at $1.50 in pre-market trading as of 2026-10-13 10:17:00, unchanged from the previous close of $1.50

Pre-market trading shows how investors are pricing EQ before the regular session opens. The current pre-market price is near the previous close, indicating neutral early trading sentiment.

Equillium, Inc. (EQ) 7-Day Stock Price Change

Over the past seven days, Equillium, Inc. (EQ) moved from $1.41 to $1.50, representing a gain of 6.38% ($0.09).

The stock traded between $1.30 and $1.60 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 574.02 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

EQ 52-Week Price Position

Position in Range: 26.7%

52W Low$0.76

52W High$3.54

EQ is currently trading at $1.50, placing it 26.7% of the way from its 52-week low of $0.76 to its 52-week high of $3.54. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Equillium, Inc. (EQ)?

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Equillium, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	14
Exchange	NASDAQ
Company Website	https://www.equilliumbio.com

How to Buy Equillium, Inc. (EQ) Stock on MEXC

Eligible investors can buy real shares of Equillium, Inc. (EQ) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for EQ and Place Your Order

Open the RealStocks trading page and search for EQ. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Equillium, Inc. (EQ) stock price today?

Equillium, Inc. (EQ) is currently trading at $ 1.50, unchanged from the previous close of $ 1.50. Intraday prices update in real time during regular trading hours.

2.Is EQ stock going up or down today?

As of 2026-10-13 10:17:00, EQ is trading at $ 1.50, unchanged from its previous close of $ 1.50. The stock has traded between $ 0.27 and $ 65.50 during today’s regular session. Past price movements do not guarantee future results.

3.What is EQ pre-market price?

As of 2026-10-13 10:17:00, EQ is trading at $ 1.50 in pre-market trading, unchanged from the previous close of $ 1.50. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is EQ after-hours price?

As of 2026-10-13 10:17:00, EQ is trading at $ 1.50 in after-hours trading, unchanged from the regular-session close of $ 1.50. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is EQ stock trading now?

EQ trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does EQ sit relative to its 52-week high and low?

Over the past 52 weeks, EQ has traded between a low of $ 0.76 and a high of $ 3.54. At $ 1.50, the stock is positioned 26.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Equillium, Inc. in?

Equillium, Inc. (EQ) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Equillium, Inc.'s market capitalisation and where is it listed?

Equillium, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 89.41M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is EQ valued in terms of P/E ratio and EPS?

EQ trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.28. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Equillium, Inc. pay a dividend?

Equillium, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.